Anzeige
Mehr »
Login
Donnerstag, 29.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
Das 13. Patent - 40% der Weltbevölkerung als potentielle Kunden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QNWR ISIN: US8808811074 Ticker-Symbol: 430 
Frankfurt
28.07.21
19:55 Uhr
6,620 Euro
+0,260
+4,09 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TERNS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
TERNS PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,8007,00028.07.

Aktuelle News zur TERNS PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
24.06.Terns Pharmaceuticals, Inc.: Terns Announces Initiation of Patient Dosing in AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201-
14.06.Terns Pharmaceuticals, Inc. - 8-K, Current Report-
14.06.Lilly-backed Terns tees up combo trial as oral NASH drug shows promise in phase 22
TERNS PHARMACEUTICALS Aktie jetzt für 0€ handeln
14.06.Terns Pharmaceuticals touts safety data from an ex-Eli Lilly candidate in the hunt for NASH treatment 4
14.06.Terns Pharmaceuticals up 9% on positive phase 2 NASH data1
14.06.Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study-
14.06.Terns Pharmaceuticals, Inc.: Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH1
13.06.Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals to Host Conference Call to Discuss Top-line Results from Phase 2a LIFT Study of TERN-101 for Treatment ...1
07.04.Terns Pharmaceuticals, Inc.: Terns to Present at the 19th Annual Virtual Needham HealthCare Conference1
06.04.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 06.04.2021507The following instruments on XETRA do have their first trading 06.04.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 06.04.2021 Aktien 1 US6612041078 North Mountain Merger...
► Artikel lesen
30.03.Terns Pharmaceuticals, Inc. - 8-K, Current Report1
30.03.Terns Pharmaceuticals reports Q4 results3
30.03.Terns Pharmaceuticals, Inc.: Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update1
26.03.The Promises Behind Terns' Multi-Pronged Pipeline-
22.03.Terns Pharmaceuticals, Inc.: Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment ...1
23.02.Terns Pharmaceuticals, Inc.: Terns to Present at the Cowen 41st Annual Health Care Conference-
10.02.Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares2
09.02.Terns Pharmaceuticals, Inc. - 8-K, Current Report-
05.02.NASH biotech Terns Pharmaceuticals opened at $16.95, below IPO price of $174
05.02.NASH biotech Terns Pharmaceuticals prices upsized IPO at $17 high end1
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1